Home > > > > Report Detail

Fibromyalgia - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Fibromyalgia - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Fibromyalgia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Fibromyalgia Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Fibromyalgia in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Fibromyalgia outlook. It also includes the explanation of changing trends of epidemiology outlining the Fibromyalgia scenario.

Fibromyalgia Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Fibromyalgia thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Fibromyalgia explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Fibromyalgia Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Fibromyalgia

Key assessments

- Patient Segmentation in Fibromyalgia

- Fibromyalgia Risk & Burden

- Factors driving growth in a specific Fibromyalgia patient population

Fibromyalgia - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Fibromyalgia Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Fibromyalgia in 2016
2.2. Patient Share Distribution of Fibromyalgia in 2028
3. Disease Background and Overview: Fibromyalgia
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Fibromyalgia in 7MM
4.3. Total Prevalent/ Incident Patient Population of Fibromyalgia in 7MM - By Countries
5. Epidemiology of Fibromyalgia by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Fibromyalgia
5.1.3. Sub-Type Specific cases of the Fibromyalgia *
5.1.4. Sex- Specific Cases of the Fibromyalgia *
5.1.5. Diagnosed Cases of the Fibromyalgia
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Fibromyalgia
5.4.3. Sub-Type Specific cases of the Fibromyalgia *
5.4.4. Sex- Specific Cases of the Fibromyalgia *
5.4.5. Diagnosed Cases of the Fibromyalgia
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Fibromyalgia
5.5.3. Sub-Type Specific cases of the Fibromyalgia *
5.5.4. Sex- Specific Cases of the Fibromyalgia *
5.5.5. Diagnosed Cases of the Fibromyalgia
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Fibromyalgia
5.6.3. Sub-Type Specific cases of the Fibromyalgia *
5.6.4. Sex- Specific Cases of the Fibromyalgia *
5.6.5. Diagnosed Cases of the Fibromyalgia
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Fibromyalgia
5.7.3. Sub-Type Specific cases of the Fibromyalgia *
5.7.4. Sex- Specific Cases of the Fibromyalgia *
5.7.5. Diagnosed Cases of the Fibromyalgia
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Fibromyalgia
5.8.3. Sub-Type Specific cases of the Fibromyalgia *
5.8.4. Sex- Specific Cases of the Fibromyalgia *
5.8.5. Diagnosed Cases of the Fibromyalgia
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Fibromyalgia
5.9.3. Sub-Type Specific cases of the Fibromyalgia *
5.9.4. Sex- Specific Cases of the Fibromyalgia *
5.9.5. Diagnosed Cases of the Fibromyalgia
6. Unmet Needs of the Fibromyalgia
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Fibromyalgia in 7MM
Table 2: Total Prevalent/Incident Cases of the Fibromyalgia in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Fibromyalgia in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Fibromyalgia in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Fibromyalgia in United States (2016-2028)*
Table 6: Diagnosed Cases of the Fibromyalgia in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Fibromyalgia in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Fibromyalgia in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Fibromyalgia in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Fibromyalgia in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Fibromyalgia in France (2016-2028)
Table 12: Sub-Type Specific cases of the Fibromyalgia in France (2016-2028) *
Table 13: Sex- Specific Cases of the Fibromyalgia in France (2016-2028) *
Table 14: Diagnosed Cases of the Fibromyalgia in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Fibromyalgia in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Fibromyalgia in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Fibromyalgia in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Fibromyalgia in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Fibromyalgia in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Fibromyalgia in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Fibromyalgia in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Fibromyalgia in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Fibromyalgia in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Fibromyalgia in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Fibromyalgia in UK (2016-2028) *
Table 26: Diagnosed Cases of the Fibromyalgia in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Fibromyalgia in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Fibromyalgia in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Fibromyalgia in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Fibromyalgia in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Fibromyalgia in 7MM
Figure 2: Total Prevalent/Incident Cases of the Fibromyalgia in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Fibromyalgia in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Fibromyalgia in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Fibromyalgia in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Fibromyalgia in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Fibromyalgia in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Fibromyalgia in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Fibromyalgia in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Fibromyalgia in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Fibromyalgia in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Fibromyalgia in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Fibromyalgia in France (2016-2028) *
Figure 14: Diagnosed Cases of the Fibromyalgia in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Fibromyalgia in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Fibromyalgia in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Fibromyalgia in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Fibromyalgia in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Fibromyalgia in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Fibromyalgia in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Fibromyalgia in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Fibromyalgia in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Fibromyalgia in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Fibromyalgia in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Fibromyalgia in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Fibromyalgia in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Fibromyalgia in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Fibromyalgia in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Fibromyalgia in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Fibromyalgia in Japan (2016-2028)

  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs